Editorial

DOI: 10.4244/EIJ-E-26-00002

Standardising the complexity of contemporary PCI

Gennaro Giustino, MD

The field of percutaneous coronary intervention (PCI) has evolved substantially over the last 3 decades1. Initially performed mostly among patients with single, focal coronary lesions, PCI is now being applied across the entire spectrum of coronary artery disease complexity1. Technological innovations and iterations in drug-eluting stent platforms, intravascular imaging, plaque modification, antithrombotic therapies, and mechanical circulatory support have made this possible2. Currently, it is estimated that approximately 30% of patients undergo complex PCI procedures. However, a universally accepted definition of “complex PCI” does not exist. About 10 years ago, at a time when there was intense debate on the optimal duration of dual antiplatelet therapy post-PCI, we first proposed an intuitive and easy-to-use definition of “complex PCI” to try to identify patients at higher risk of ischaemic events who may derive a greater benefit from prolonged or more intense antithrombotic therapies3. Since then, the criteria for complex PCI have been evaluated in many subsequent observational studies and subgroup analyses of randomised controlled trials and have been endorsed by the European Society of Cardiology (ESC) and the...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 22 Number 7
Apr 6, 2026
Volume 22 Number 7
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-25-01204 Apr 6, 2026
Ischaemic and bleeding events after complex versus non-complex PCI: a systematic review and meta-analysis
Piccolo R et al

10.4244/EIJV16I7A100 Sep 18, 2020
Complex PCI: time for a universal definition
Wykrzykowska JJ and Kerkmeijer L
free

Editorial

10.4244/EIJ-E-24-00066 Jan 6, 2025
Managing the device-related risk of in-stent restenosis and stent thrombosis in coronary stenting
Lassen J and Jensen L
free

10.4244/EIJ-E-21-00011 Mar 18, 2022
Another way to measure the progress of PCI
King S
free

10.4244/EIJV15I11A174 Dec 6, 2019
Antiplatelet strategies for complex PCI
Capodanno D
free

Expert review

10.4244/EIJ-D-19-01124 Apr 17, 2020
The year in review: coronary interventions
Gao C et al
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved